Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
China flag China · Delayed Price · Currency is CNY
4.480
0.00 (0.00%)
Feb 3, 2026, 3:00 PM CST

SHA:600572 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
835.81,3222,5702,4682,5731,575
Trading Asset Securities
-----1.8
Cash & Short-Term Investments
835.81,3222,5702,4682,5731,577
Cash Growth
4.06%-48.56%4.13%-4.09%63.19%-7.47%
Accounts Receivable
1,8931,6651,7561,6381,6711,405
Other Receivables
84.7987.7438.2259.4184.4296.53
Receivables
1,9781,7531,7941,6971,7551,501
Inventory
1,1461,2661,3331,1281,044961.46
Prepaid Expenses
-0.260.610.891.024.78
Other Current Assets
715.1778.1877.26101.7492.1792.95
Total Current Assets
4,6744,4195,7755,3955,4664,138
Property, Plant & Equipment
2,8983,0473,0483,2203,2513,033
Long-Term Investments
1,9061,7741,7231,6291,8811,435
Goodwill
184.72184.72184.72184.72184.72172.61
Other Intangible Assets
378.73349.19355.45390.79362.43377.82
Long-Term Deferred Tax Assets
29.0841.1678.9455.4627.532.67
Long-Term Deferred Charges
20.8367.4646.3540.6666.8151.47
Other Long-Term Assets
41.519.3125.8614.8234.7838.61
Total Assets
10,1339,90211,23810,93111,2749,279
Accounts Payable
957.43984.41819.53629.13540.19270.97
Accrued Expenses
200.43963.411,2051,005873.5821.29
Short-Term Debt
231.28210.56849.71717.731,3441,748
Current Portion of Long-Term Debt
98.9991.0777.79138.63129.65-
Current Portion of Leases
-2.234.46.154.63-
Current Income Taxes Payable
106.8544.8456.4551.3828.562.93
Current Unearned Revenue
24.9437.6843.65113.336.6841.97
Other Current Liabilities
928.28182.23115.87128.07210.8307.18
Total Current Liabilities
2,5482,5163,1732,7893,1683,253
Long-Term Debt
70.05117.87305.03330.39.5502.71
Long-Term Leases
1.392.050.723.974-
Long-Term Unearned Revenue
114.76116.21141.11154.22146.8398.61
Long-Term Deferred Tax Liabilities
236.58235.6268.27328.79310.374.31
Other Long-Term Liabilities
0.960.940.930.920.920.73
Total Liabilities
2,9722,9893,8893,6073,6393,929
Common Stock
2,5252,5832,5702,5702,5702,667
Additional Paid-In Capital
258.81285.66210.32149.54359.76677.13
Retained Earnings
4,2784,2514,2614,1944,2712,267
Treasury Stock
--299.99----585.15
Comprehensive Income & Other
-0.01-0.11-0.010.10.270.28
Total Common Equity
7,0626,8207,0416,9147,2015,026
Minority Interest
99.6892.97308.58410.18434.01323.25
Shareholders' Equity
7,1616,9137,3507,3247,6355,349
Total Liabilities & Equity
10,1339,90211,23810,93111,2749,279
Total Debt
401.71423.771,2381,1971,4922,251
Net Cash (Debt)
434.09898.341,3321,2711,082-674.33
Net Cash Growth
13.48%-32.57%4.81%17.53%--
Net Cash Per Share
0.170.350.520.500.42-0.27
Filing Date Shares Outstanding
2,5252,5192,5702,5702,5702,570
Total Common Shares Outstanding
2,5252,5192,5702,5702,5702,570
Working Capital
2,1261,9022,6032,6062,298884.71
Book Value Per Share
2.802.712.742.692.801.96
Tangible Book Value
6,4986,2866,5016,3386,6544,476
Tangible Book Value Per Share
2.572.492.532.472.591.74
Buildings
-2,4272,2502,1382,0552,064
Machinery
-2,7652,6552,2791,8881,921
Construction In Progress
-139.45238.37661.931,068598.64
Source: S&P Global Market Intelligence. Standard template. Financial Sources.